Glomerulonephritis Treatment
肾小球肾炎治疗
Duration
3-12 months induction; years of maintenance
Recovery
Weeks to months depending on disease type and severity
Savings
~86% vs US
Average savings compared to US prices
Specialized treatment of various glomerulonephritis subtypes including lupus nephritis, ANCA-associated vasculitis, and anti-GBM disease at China's leading nephrology departments. Treatment protocols follow international guidelines with access to biological agents, plasma exchange, and immunosuppressive combinations. High patient volumes ensure significant clinical expertise in managing these complex conditions.
Comprehensive Evaluation
Autoimmune serologies, complement levels, biopsy if needed, and systemic disease assessment
Duration: 3-5 daysInduction Therapy
High-dose immunosuppression with cyclophosphamide, rituximab, or mycophenolate depending on subtype
Duration: 3-6 monthsPlasma Exchange if Indicated
Therapeutic plasmapheresis for rapidly progressive or anti-GBM disease presentations
Duration: 2-3 weeksMaintenance Therapy
Long-term immunosuppression with monitoring for relapse and treatment toxicity
Duration: 2-5 years- Expert management of rare glomerular diseases
- Access to rituximab and biologics at lower cost
- Plasma exchange capabilities at specialized centers
- Multidisciplinary approach for systemic autoimmune conditions
- Serious infections from immunosuppression
- Infertility risk with cyclophosphamide
- Malignancy risk with long-term immunosuppression
- Disease relapse requiring retreatment
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.